Avalo Therapeutics, Inc. · NASDAQ:AVTX

Balyasny Asset Management L.P.'s stake in Avalo Therapeutics, Inc. fell to 2.42% (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

Balyasny Asset Management L.P.'s stake in Avalo Therapeutics, Inc. fell to 2.42%, 439,312 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
2.42%
Shares
439,312
Intent
Passive
What changed
Fell below 5%
Filed together
5 holders

The filing in full

HolderStakeShares
Balyasny Asset Management L.P.2.42%439,312
BAM GP LLC2.42%439,312
Balyasny Asset Management Holdings LP2.42%439,312
Dames GP LLC2.42%439,312
Dmitry Balyasny2.42%439,312

Source

View original at SEC

Related